RAPT Therapeutics, Inc. (RAPT)
NASDAQ: RAPT · Real-Time Price · USD
0.825
+0.018 (2.18%)
At close: Dec 20, 2024, 4:00 PM
0.850
+0.024 (2.93%)
After-hours: Dec 20, 2024, 5:08 PM EST
RAPT's stock price has decreased by -96.18% in the past year and price targets may not have had time to catch up.
RAPT Therapeutics Analyst Ratings
Total Analysts
10
Consensus Rating
Hold
Price Target
$5.00
Upside
+505.77%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Nov 25, 2024 |
| Wells Fargo | Wells Fargo | Buy Maintains $17 → $4 | Buy | Maintains | $17 → $4 | +384.61% | Nov 12, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Nov 12, 2024 |
| JP Morgan | JP Morgan | Hold → Sell Downgrades n/a | Hold → Sell | Downgrades | n/a | n/a | Nov 11, 2024 |
| UBS | UBS | Hold Maintains $10 → $2 | Hold | Maintains | $10 → $2 | +142.31% | Sep 9, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Aug 20, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Jul 23, 2024 |
| Wolfe Research | Wolfe Research | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | May 14, 2024 |
| Barclays | Barclays | Buy → Hold Downgrades $13 → $4 | Buy → Hold | Downgrades | $13 → $4 | +384.61% | May 10, 2024 |
| Guggenheim | Guggenheim | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | May 10, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Apr 10, 2024 |
| JP Morgan | JP Morgan | Hold Maintains $15 → $13 | Hold | Maintains | $15 → $13 | +1,474.99% | Mar 27, 2024 |
| UBS | UBS | Strong Buy → Hold Downgrades $61 → $10 | Strong Buy → Hold | Downgrades | $61 → $10 | +1,111.53% | Feb 22, 2024 |
| Barclays | Barclays | Buy Maintains $35 → $13 | Buy | Maintains | $35 → $13 | +1,474.99% | Feb 21, 2024 |
| Leerink Partners | Leerink Partners | Buy → Hold Downgrades $10 | Buy → Hold | Downgrades | $10 | +1,111.53% | Feb 21, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Feb 21, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.